Pathologic complete response with pembrolizumab plus axitinib in metastatic renal cell carcinoma
In this study, we report a case of a patient with metastatic renal cell carcinoma who was treated with pembrolizumab plus axitinib, followed by resection of the primary tumor and metastatic lesions, and pathologically achieved a complete response.
Source: International Cancer Conference Journal - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Conferences | Kidney Cancer | Renal Cell Carcinoma | Study